Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Feasibility of Fingerprick Autologous Blood (FAB) As a Novel Treatment for Severe Dry Eye Disease (DED)

NCT03395431 is registered in ClinicalTrials.gov with Bedford Hospital NHS Trust as lead sponsor.

NCT NCT03395431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03395431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Feasibility of Fingerprick Autologous Blood (FAB) As a Novel Treatment for Severe Dry Eye Disease (DED)
Lead sponsor
Bedford Hospital NHS Trust
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2018
Completion date
July 31, 2019
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndromes